India

India

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.65 (1.33 - 2.02) 2015 Modelled WHO
2.5 (2.20 - 2.70) 2016 Modelled Razavi-Shearer et al, 2018
1.46 (1.44 - 1.47) 2013 Modelled Schweitzer et al, 2015
3.07 (3.17 - 4.24) 2009 Modelled Batham et al, 2009
1 2001 Modelled Lodha et al, 2001
3.7 2014 Modelled National Centre for Disease Control, 2014
4 1996 Modelled Tandon et al, 1996
2.93 (2.57 - 3.29) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.14 (2.76 - 3.53) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.17 (2.78 - 3.56) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.21 (2.81 - 3.60) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.23 (2.84 - 3.63) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.28 (2.87 - 3.68) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.36 (2.93 - 3.78) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.47 (3.03 - 3.90) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (3.11 - 4) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.61 (3.16 - 4.06) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.64 (3.18 - 4.09) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (3.20 - 4.13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.69 (3.23 - 4.15) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.71 (3.24 - 4.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (3.25 - 4.20) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.74 (3.26 - 4.21) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.75 (3.27 - 4.24) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.76 (3.28 - 4.25) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (3.29 - 4.27) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.78 (3.30 - 4.28) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.79 (3.30 - 4.29) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (3.32 - 4.30) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (3.32 - 4.31) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.82 (3.33 - 4.33) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.83 (3.33 - 4.34) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.84 (3.34 - 4.35) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.85 (3.35 - 4.38) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.86 (3.35 - 4.40) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.88 (3.36 - 4.42) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.89 (3.38 - 4.44) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.1 (2.72 - 3.47) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.51 (0.38 - 0.65) 2015 Modelled WHO
0.52 (0.42 - 0.63) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.58 (0.47 - 0.70) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.50 - 0.75) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.53 - 0.79) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.56 - 0.83) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.60 - 0.88) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.73 - 1.08) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.2 (0.98 - 1.45) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.55 (1.26 - 1.88) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.50 - 2.24) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.62 - 2.44) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (1.71 - 2.57) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.25 (1.83 - 2.74) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.4 (1.95 - 2.92) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.52 (2.05 - 3.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.09 - 3.12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.09 - 3.14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.09 - 3.14) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.09 - 3.14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.08 - 3.14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (2.08 - 3.13) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (2.07 - 3.11) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (2.07 - 3.11) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (2.06 - 3.11) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.06 - 3.10) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.06 - 3.09) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.06 - 3.10) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.05 - 3.10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.05 - 3.11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (2.05 - 3.12) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (2.05 - 3.14) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.14 - 0.19) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
32,703,000 (29,547,000 - 35,907,000) 2016 Modelled Razavi-Shearer et al, 2018
40,721,600 (35,674,300 - 45,819,700) 2019 Modelled IHME, GBD 2019 (accessed 2020)
42,052,300 (36,912,100 - 47,230,700) 2019 Modelled IHME, GBD 2019 (accessed 2022)
42,135,600 (37,006,500 - 47,477,200) 2018 Modelled IHME, GBD 2019 (accessed 2022)
42,050,800 (36,815,300 - 47,288,800) 2017 Modelled IHME, GBD 2019 (accessed 2022)
41,982,300 (36,746,400 - 47,077,000) 2016 Modelled IHME, GBD 2019 (accessed 2022)
41,808,700 (36,634,300 - 46,867,600) 2015 Modelled IHME, GBD 2019 (accessed 2022)
41,774,300 (36,558,900 - 46,866,500) 2014 Modelled IHME, GBD 2019 (accessed 2022)
42,287,700 (36,943,400 - 47,452,500) 2013 Modelled IHME, GBD 2019 (accessed 2022)
42,982,800 (37,550,900 - 48,269,200) 2012 Modelled IHME, GBD 2019 (accessed 2022)
43,499,200 (37,915,600 - 48,860,500) 2011 Modelled IHME, GBD 2019 (accessed 2022)
43,485,000 (37,949,500 - 48,859,100) 2010 Modelled IHME, GBD 2019 (accessed 2022)
43,108,700 (37,652,400 - 48,507,200) 2009 Modelled IHME, GBD 2019 (accessed 2022)
42,746,300 (37,329,000 - 48,126,900) 2008 Modelled IHME, GBD 2019 (accessed 2022)
42,358,600 (36,996,500 - 47,740,200) 2007 Modelled IHME, GBD 2019 (accessed 2022)
41,902,100 (36,598,300 - 47,221,400) 2006 Modelled IHME, GBD 2019 (accessed 2022)
41,337,100 (36,092,800 - 46,670,400) 2005 Modelled IHME, GBD 2019 (accessed 2022)
40,718,600 (35,519,500 - 45,965,100) 2004 Modelled IHME, GBD 2019 (accessed 2022)
40,124,800 (34,984,200 - 45,348,600) 2003 Modelled IHME, GBD 2019 (accessed 2022)
39,545,200 (34,469,600 - 44,733,700) 2002 Modelled IHME, GBD 2019 (accessed 2022)
38,960,600 (33,947,700 - 44,095,900) 2001 Modelled IHME, GBD 2019 (accessed 2022)
38,351,300 (33,437,600 - 43,487,200) 2000 Modelled IHME, GBD 2019 (accessed 2022)
37,736,900 (32,880,300 - 42,768,400) 1999 Modelled IHME, GBD 2019 (accessed 2022)
37,143,100 (32,377,000 - 42,090,000) 1998 Modelled IHME, GBD 2019 (accessed 2022)
36,560,600 (31,838,200 - 41,418,500) 1997 Modelled IHME, GBD 2019 (accessed 2022)
35,973,600 (31,311,900 - 40,768,900) 1996 Modelled IHME, GBD 2019 (accessed 2022)
35,375,800 (30,776,600 - 40,102,400) 1995 Modelled IHME, GBD 2019 (accessed 2022)
34,793,100 (30,233,000 - 39,467,700) 1994 Modelled IHME, GBD 2019 (accessed 2022)
34,246,700 (29,744,700 - 38,928,200) 1993 Modelled IHME, GBD 2019 (accessed 2022)
33,730,600 (29,282,600 - 38,404,500) 1992 Modelled IHME, GBD 2019 (accessed 2022)
33,236,000 (28,786,000 - 37,890,700) 1991 Modelled IHME, GBD 2019 (accessed 2022)
32,753,900 (28,412,800 - 37,369,600) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.94 (6.43 - 9.69) 2019 Modelled IHME, GBD 2019 (accessed 2020)
7.05 (5.78 - 8.95) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.9 (5.59 - 8.89) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.73 (5.40 - 8.79) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.75 (5.49 - 8.57) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.83 (5.64 - 8.63) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.81 (5.63 - 8.54) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.99 (5.78 - 8.67) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7.35 (6.08 - 9.24) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7.49 (6.24 - 9.36) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7.57 (6.37 - 9.29) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7.66 (6.47 - 9.29) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7.79 (6.59 - 9.46) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7.87 (6.72 - 9.36) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7.84 (6.75 - 9.17) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7.97 (6.96 - 9.28) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7.75 (6.78 - 8.92) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8.1 (7.13 - 9.34) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8.23 (7.18 - 9.42) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8.37 (7.27 - 9.63) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8.22 (7.25 - 9.36) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8.18 (7.15 - 9.52) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.45 (7.42 - 9.78) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8.65 (7.54 - 9.96) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8.78 (7.62 - 10.16) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8.66 (7.53 - 9.84) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8.85 (7.85 - 10.03) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8.33 (7.30 - 9.51) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7.72 (6.62 - 9.11) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7.75 (6.45 - 9.25) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7.94 (6.43 - 9.69) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
211,729 2016 Modelled WHO
60,291 (49,476 - 76,584) 1990 Modelled IHME, GBD 2019 (accessed 2022)
60,174 (48,704 - 77,507) 1991 Modelled IHME, GBD 2019 (accessed 2022)
59,792 (47,927 - 78,040) 1992 Modelled IHME, GBD 2019 (accessed 2022)
61,078 (49,677 - 77,517) 1993 Modelled IHME, GBD 2019 (accessed 2022)
66,954 (55,317 - 83,044) 1996 Modelled IHME, GBD 2019 (accessed 2022)
62,944 (51,983 - 79,537) 1994 Modelled IHME, GBD 2019 (accessed 2022)
64,012 (52,924 - 80,213) 1995 Modelled IHME, GBD 2019 (accessed 2022)
71,756 (59,348 - 90,193) 1997 Modelled IHME, GBD 2019 (accessed 2022)
74,487 (62,088 - 93,036) 1998 Modelled IHME, GBD 2019 (accessed 2022)
76,670 (64,485 - 94,108) 1999 Modelled IHME, GBD 2019 (accessed 2022)
79,032 (66,733 - 95,908) 2000 Modelled IHME, GBD 2019 (accessed 2022)
81,842 (69,274 - 99,382) 2001 Modelled IHME, GBD 2019 (accessed 2022)
84,291 (71,956 - 100,143) 2002 Modelled IHME, GBD 2019 (accessed 2022)
85,480 (73,581 - 99,939) 2003 Modelled IHME, GBD 2019 (accessed 2022)
86,091 (75,253 - 99,045) 2004 Modelled IHME, GBD 2019 (accessed 2022)
90,109 (78,681 - 104,985) 2005 Modelled IHME, GBD 2019 (accessed 2022)
93,218 (82,115 - 107,481) 2006 Modelled IHME, GBD 2019 (accessed 2022)
96,464 (84,073 - 110,368) 2007 Modelled IHME, GBD 2019 (accessed 2022)
99,790 (86,619 - 114,705) 2008 Modelled IHME, GBD 2019 (accessed 2022)
99,151 (86,579 - 115,371) 2009 Modelled IHME, GBD 2019 (accessed 2022)
105,689 (92,861 - 122,282) 2011 Modelled IHME, GBD 2019 (accessed 2022)
101,206 (89,325 - 115,311) 2010 Modelled IHME, GBD 2019 (accessed 2022)
109,812 (95,792 - 126,482) 2012 Modelled IHME, GBD 2019 (accessed 2022)
113,142 (98,149 - 130,910) 2013 Modelled IHME, GBD 2019 (accessed 2022)
113,173 (98,457 - 128,534) 2014 Modelled IHME, GBD 2019 (accessed 2022)
117,169 (103,923 - 132,794) 2015 Modelled IHME, GBD 2019 (accessed 2022)
111,723 (97,971 - 127,677) 2016 Modelled IHME, GBD 2019 (accessed 2022)
104,943 (89,974 - 123,779) 2017 Modelled IHME, GBD 2019 (accessed 2022)
106,614 (88,685 - 127,169) 2018 Modelled IHME, GBD 2019 (accessed 2022)
110,372 (89,416 - 134,741) 2019 Modelled IHME, GBD 2019 (accessed 2022)
110,372 (89,416 - 134,741) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
6 (5 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 9) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 10) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 11) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 12) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 12) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 13) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 13) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 13) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 13) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 13) 2018 Modelled IHME, GBD 2019 (accessed 2022)
35 (31 - 40) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
56 2019 Survey/reported WHO/UNICEF
54 2018 Survey/reported WHO/UNICEF
54 2017 Survey/reported WHO/UNICEF
47 2016 Survey/reported WHO/UNICEF
44 2015 Survey/reported WHO/UNICEF
41 2014 Survey/reported WHO/UNICEF
37 2013 Survey/reported WHO/UNICEF
23 2012 Survey/reported WHO/UNICEF
8 2011 Survey/reported WHO/UNICEF
8 2010 Survey/reported WHO/UNICEF
8 2009 Survey/reported WHO/UNICEF
8 2008 Survey/reported WHO/UNICEF
54 2020 Survey/reported WHO/UNICEF
55 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2019 Survey/reported WHO/UNICEF
85 2020 Survey/reported WHO/UNICEF
85 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
86 (63 - 133) 2015 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2008
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.40 - 0.80) 2015 Modelled Blach et al, 2017
0.7 (0.40 - 0.80) 2014 Survey/reported Gower et al, 2014
0.85 (0.69 - 1.06) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.68 - 1.05) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.67 - 1.04) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.66 - 1.01) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.64 - 0.99) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.99) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.99) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.65 - 0.99) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.65 - 1) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.65 - 0.99) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.64 - 0.97) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.94) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.59 - 0.90) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.57 - 0.87) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.56 - 0.85) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.56 - 0.85) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.56 - 0.86) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.57 - 0.88) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.58 - 0.89) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.59 - 0.91) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.61 - 0.93) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.63 - 0.96) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.65 - 1) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.67 - 1.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.68 - 1.05) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.69 - 1.06) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.69 - 1.08) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.70 - 1.09) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.70 - 1.10) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.70 - 1.10) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.67 - 1.02) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.33 (0.25 - 0.59) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.84 2019 Modelled Jin et al. 2017
0.8 (0.40 - 1) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.88 (0.21 - 1.90) 2018 Modelled Goel et al, 2018
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
3.51 (2.43 - 4.76) 2018 Modelled Goel et al, 2018
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
0 (0 - 7) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
40 (33.90 - 46.10) 2015 Modelled Degenhardt L et al, 2017
44.71 (37.50 - 52.03) 2018 Modelled Goel et al, 2018
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
0 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
6,245,000 (4,748,000 - 10,957,000) 2015 Modelled Blach et al, 2017
7,403,600 (5,894,860 - 9,244,130) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7,532,970 (6,002,730 - 9,412,880) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7,636,030 (6,088,410 - 9,505,440) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7,718,120 (6,180,880 - 9,584,490) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7,784,940 (6,263,440 - 9,647,060) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7,841,200 (6,316,870 - 9,701,380) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7,839,010 (6,321,000 - 9,687,600) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7,750,660 (6,252,420 - 9,571,630) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7,622,370 (6,149,210 - 9,409,420) 1998 Modelled IHME, GBD 2019 (accessed 2022)
7,508,040 (6,055,680 - 9,266,040) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7,463,620 (6,019,070 - 9,194,900) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7,466,520 (6,026,220 - 9,207,520) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7,467,370 (6,031,330 - 9,215,320) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7,490,190 (6,047,960 - 9,236,920) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7,561,170 (6,098,910 - 9,329,690) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7,704,610 (6,212,460 - 9,489,120) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7,992,830 (6,451,950 - 9,852,910) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8,425,180 (6,805,570 - 10,397,000) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8,914,980 (7,191,250 - 10,996,400) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9,370,420 (7,545,990 - 11,548,200) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9,690,860 (7,806,160 - 11,948,600) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9,870,120 (7,961,490 - 12,176,200) 2011 Modelled IHME, GBD 2019 (accessed 2022)
9,992,220 (8,084,700 - 12,320,500) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10,090,100 (8,144,860 - 12,438,200) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10,200,500 (8,213,420 - 12,569,500) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10,364,000 (8,331,580 - 12,782,300) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10,724,700 (8,654,120 - 13,240,200) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11,114,500 (8,936,260 - 13,741,900) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11,373,100 (9,142,310 - 14,053,800) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11,591,500 (9,325,550 - 14,307,100) 2019 Modelled IHME, GBD 2019 (accessed 2022)
11,517,600 (9,254,770 - 14,224,500) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
1,182,000 (898,000 - 2,073,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
4.8 (3.94 - 5.81) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.85 (3.19 - 4.84) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.92 (3.23 - 4.94) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.97 (3.27 - 4.97) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.08 (3.39 - 5.10) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.19 (3.56 - 5.13) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.2 (3.57 - 5.17) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.29 (3.67 - 5.25) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.5 (3.83 - 5.45) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.47 (3.80 - 5.50) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.5 (3.87 - 5.45) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.53 (3.91 - 5.43) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.65 (4.05 - 5.49) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.6 (3.97 - 5.46) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.62 (4.03 - 5.36) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.55 (3.99 - 5.26) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.67 (4.10 - 5.34) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.77 (4.20 - 5.48) 2006 Modelled IHME, GBD 2019 (accessed 2022)
4.89 (4.29 - 5.61) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.03 (4.42 - 5.77) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4.99 (4.37 - 5.69) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.94 (4.33 - 5.71) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (4.41 - 5.74) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.82 (4.25 - 5.55) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.61 (4.01 - 5.39) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.35 (3.79 - 5.03) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.34 (3.79 - 5.02) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.44 (3.76 - 5.24) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4.37 (3.79 - 5.09) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (3.82 - 5.49) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4.8 (3.94 - 5.81) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
39,069 2016 Modelled WHO
66,699 (54,749 - 80,749) 2019 Modelled IHME, GBD 2019 (accessed 2022)
66,699 (54,749 - 80,749) 2019 Modelled IHME, GBD 2019 (accessed 2020)
62,851 (52,499 - 75,475) 2018 Modelled IHME, GBD 2019 (accessed 2022)
60,272 (51,096 - 71,162) 2017 Modelled IHME, GBD 2019 (accessed 2022)
58,659 (50,921 - 68,343) 2016 Modelled IHME, GBD 2019 (accessed 2022)
57,602 (50,216 - 66,571) 2015 Modelled IHME, GBD 2019 (accessed 2022)
56,744 (49,560 - 65,548) 2014 Modelled IHME, GBD 2019 (accessed 2022)
59,378 (51,637 - 69,428) 2013 Modelled IHME, GBD 2019 (accessed 2022)
61,209 (54,006 - 70,497) 2012 Modelled IHME, GBD 2019 (accessed 2022)
62,653 (55,193 - 71,827) 2011 Modelled IHME, GBD 2019 (accessed 2022)
61,503 (53,783 - 70,058) 2010 Modelled IHME, GBD 2019 (accessed 2022)
59,895 (52,417 - 69,210) 2009 Modelled IHME, GBD 2019 (accessed 2022)
59,880 (52,680 - 68,696) 2008 Modelled IHME, GBD 2019 (accessed 2022)
57,298 (50,300 - 65,710) 2007 Modelled IHME, GBD 2019 (accessed 2022)
54,864 (48,339 - 63,141) 2006 Modelled IHME, GBD 2019 (accessed 2022)
52,807 (46,404 - 60,340) 2005 Modelled IHME, GBD 2019 (accessed 2022)
50,471 (44,327 - 58,433) 2004 Modelled IHME, GBD 2019 (accessed 2022)
50,324 (43,939 - 58,393) 2003 Modelled IHME, GBD 2019 (accessed 2022)
49,777 (43,362 - 58,749) 2002 Modelled IHME, GBD 2019 (accessed 2022)
48,400 (41,708 - 57,421) 2001 Modelled IHME, GBD 2019 (accessed 2022)
46,772 (40,363 - 56,071) 2000 Modelled IHME, GBD 2019 (accessed 2022)
45,591 (39,168 - 55,168) 1999 Modelled IHME, GBD 2019 (accessed 2022)
44,790 (38,053 - 54,192) 1998 Modelled IHME, GBD 2019 (accessed 2022)
43,670 (37,040 - 53,631) 1997 Modelled IHME, GBD 2019 (accessed 2022)
41,096 (35,099 - 50,233) 1996 Modelled IHME, GBD 2019 (accessed 2022)
39,442 (33,546 - 48,558) 1995 Modelled IHME, GBD 2019 (accessed 2022)
38,599 (32,779 - 47,290) 1994 Modelled IHME, GBD 2019 (accessed 2022)
36,907 (30,656 - 46,173) 1993 Modelled IHME, GBD 2019 (accessed 2022)
35,268 (29,018 - 44,085) 1992 Modelled IHME, GBD 2019 (accessed 2022)
34,180 (28,186 - 43,014) 1991 Modelled IHME, GBD 2019 (accessed 2022)
32,913 (27,274 - 41,437) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
2 (2 - 3) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 3) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 3) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 3) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 5) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 2019 Modelled IHME, GBD 2019 (accessed 2022)
20 (17 - 24) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
100,000 2018 Survey/reported WHO, 2021
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
86 (63 - 133) 2015 Survey/reported Larney S et al, 2017
Technical notes

Price of HCV cure (Cheapest price in private sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
49.5 2019 Survey/reported WHO, 2021

Price of HCV cure (Average price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
91.5 2019 Survey/reported WHO, 2021

Price of HCV cure (Cheapest price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
18 2019 Survey/reported WHO, 2021

Price of HCV cure (Average price in private sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
147.9 2019 Survey/reported WHO, 2021
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2008
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No policy
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Hepatitis related deaths (national)

Modelled

HBV
110,372
2019
(89,416 - 134,741)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
66,699
2019
(54,749 - 80,749)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
55 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
86
2015
(63 - 133)
Larney S et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources